Category

Oil stocks such as BP and Royal Dutch Shell recovered as oil prices edged away from multi-year lows on Tuesday. The S&P 500 gained 16 points to 2021, while the NASDAQ added 46 points to 4969.

As Democratic presidential contenders sparred at their last debate of the year, frontrunner Hillary Clinton suggested that her Republican rival Donald Trump’s rhetoric against Muslims was becoming a potent and powerful tool for ISIS. Or, to be more precise, she called him...

Thankfully, horror stories like Gobena’s soon could become a thing of the past.

BG Group said it sent a petition related to the merger to a high court in London.

According to the ETF Finder at ETF Channel, V makes up 6.46% of the iShares U.S. Financial Services ETF (IYG) which is trading up by about 0.4% on the day Monday.

U.S. Census Bureau data show North Dakota is leading the nation in population growth and the number of residents in the state is at an all-time high.

Congress approved legislation to suspend country-of-origin labeling (COOL) for certain muscle cuts of meat that will avoid costly trade retaliation by Canada and Mexico.

WRA economist Dave Clark said it was a “solid November”, with members selling about 4,800 homes at a median price of $150,000.

The expansion will boost the port’s capacity to meet anticipated export demand from proposed coal projects in the Galilee Basin, including Indian mining giant Adani’s controversial Carmichael mine.

Stung by criticism that it jacked up the price of lifesaving medicines, Valeant Pharmaceuticals said Tuesday it will lower some prices through an agreement with Chicago-based Walgreens, the nation’s largest pharmacy retailer. The company now has an average rating of...

The U.S. benchmark crude ended last Friday at a new minimum for the year, and on Monday dropped even lower to $33.98 per barrel.

Liveris will be named executive chairman of the combined company while DuPont Chairman and CEO Edward Breen will be CEO.

Despite the discussions, and the rejection, FTC has not made any counteroffer, Staples said.

Tilles also thanked Shkreli “for helping us build Turing Pharmaceuticals into the dynamic research-focused company it is today”, a reference to Shkreli’s after-the-fact claim that he needed to raise Daraprim’s price so much to fund research on other drugs.

On Friday, Shkreli resigned from his role as chief executive of Turing Pharmaceuticals, the company that owns the rights to Daraprim. “The charges against me are baseless and without merit”, Shkreli, who is free on $5 million bond, tweeted on Saturday.